NEW YORK (GenomeWeb) – Monsanto announced today that it has obtained a global, non-exclusive licensing agreement from the Broad Institute for agricultural applications of CRISPR genome editing technology.

CRISPR-based genome editing offers "site-directed integration of specific genes as well as the opportunity to enhance beneficial [plant characteristics] or remove undesired plant characteristics," Monsanto said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Jun
19
Sponsored by
ACD

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.